Australia markets closed

MGC Pharmaceuticals Limited (MXC.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.55000.0000 (0.00%)
At close: 03:46PM AEDT
Currency in AUD

Valuation measures4

Market cap (intra-day) 19.49M
Enterprise value 19.82M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.48
Price/book (mrq)N/A
Enterprise value/revenue 5.85
Enterprise value/EBITDA -0.99

Trading information

Stock price history

Beta (5Y monthly) 1.05
52-week change 34,900.00%
S&P500 52-week change 315.38%
52-week high 32.0000
52-week low 30.0010
50-day moving average 31.1743
200-day moving average 30.2978

Share statistics

Avg vol (3-month) 31.65M
Avg vol (10-day) 311.85k
Shares outstanding 535.43M
Implied shares outstanding 636.49M
Float 84.37M
% held by insiders 14.48%
% held by institutions 11.77%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:1000
Last split date 330 Oct 2023

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)30 June 2023


Profit margin 0.00%
Operating margin (ttm)-1,008.65%

Management effectiveness

Return on assets (ttm)-66.72%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)3.39M
Revenue per share (ttm)1.15
Quarterly revenue growth (yoy)-66.30%
Gross profit (ttm)1.29M
EBITDA -14.69M
Net income avi to common (ttm)-20.82M
Diluted EPS (ttm)-7.1000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)239.82k
Total cash per share (mrq)0.05
Total debt (mrq)9.75M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.19
Book value per share (mrq)-2.21

Cash flow statement

Operating cash flow (ttm)-11.99M
Levered free cash flow (ttm)-5.55M